In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Versicor merges with Biosearch Italia in $234mm stock swap

Executive Summary

Anti-infectives specialist Versicor plans to acquire antibiotic developer Biosearch Italia in a stock-for-stock transaction totaling about Euro236mm ($234.3mm). Versicor will issue 1.77 shares of its own stock (worth $19.27) for each Biosearch outstanding share, a 38% premium over market average.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register